StreetInsider.com News Articles

Septerna to Participate in Upcoming Investor Conferences

Tue, 01 Sep 2026 08:00:00 -0400

SOUTH SAN FRANCISCO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that management will participate in the following investor conferences in September:

Wells Fargo 21^st Annual Healthcare Conference
Fireside chat on Tuesday, September 8, 2026, at 8:00 a.m. ET

Cantor Global Healthcare Conference 2026
Fireside chat on Thursday, September 10, 2026, at 11:30 a.m. ET

A live webcast of each presentation will be available in the investors section of the company’s website at

Septerna to Participate in Upcoming Investor Conferences

Tue, 01 Sep 2026 08:00:00 -0400

Wells Fargo 21^st Annual Healthcare Conference
Fireside chat on Tuesday, September 8, 2026, at 8:00 a.m. ET

Cantor Global Healthcare Conference 2026
Fireside chat on Thursday, September 10, 2026, at 11:30 a.m. ET

A live webcast of each presentation will be available in the investors section of the company’s website at

Form 8-K Septerna, Inc. For: Aug 22

Tue, 25 Aug 2026 08:15:00 -0400

si-local-file:///var/storage/secattach/20260825/26971229.html

Form 8-K Septerna, Inc. For: Aug 22

Tue, 25 Aug 2026 08:15:00 -0400

si-local-file:///var/storage/secattach/20260825/26971229.html

Septerna names Rajiv Patni as chief medical officer

Tue, 25 Aug 2026 08:00:14 -0400

Septerna, Inc. (Nasdaq: SEPN) has appointed Rajiv Patni, M.D., as chief medical officer, the clinical-stage biotechnology company announced.

Dr. Patni joins Septerna from Judo Bio, where he most recently served as chief executive officer. Before that, he was chief research and development officer at Reata Pharmaceuticals. He has also served as chief medical officer at Global Blood Therapeutics, Portola Pharmaceuticals, Adamas Pharmaceuticals, and Actelion Pharmaceuticals. Earlier in his career, he held development roles at Pfizer and Roche Pharmaceuticals.

Over his more than 25-year career, Dr. Patni has contributed to programs resulting in 10 regulatory approvals or label expansions across the United States,

Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer

Tue, 25 Aug 2026 08:00:00 -0400

SOUTH SAN FRANCISCO, Calif., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced the appointment of Rajiv Patni, M.D., as Chief Medical Officer. Dr. Patni is a physician-scientist and accomplished biopharmaceutical executive with more than 25 years of experience leading research, development, regulatory, and medical affairs organizations.

“We are thrilled to welcome Rajiv to the team as we execute on our strategy to develop differentiated oral medicines targeting GPCRs,” said Jeffrey Finer, M.D., Ph.D., Chief Executive Officer and

Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer

Tue, 25 Aug 2026 08:00:00 -0400

“We are thrilled to welcome Rajiv to the team as we execute on our strategy to develop differentiated oral medicines targeting GPCRs,” said Jeffrey Finer, M.D., Ph.D., Chief Executive Officer and

Septerna Inc (SEPN) PT Raised to $48 at JPMorgan

Wed, 19 Aug 2026 07:59:23 -0400

JPMorgan analyst Tessa Romero raised the price target on Septerna Inc (NASDAQ: SEPN) to $48.00 (from $38.00) while maintaining a Overweight rating.

Form 4 Septerna, Inc. For: Aug 12 Filed by: Third Rock Ventures GP VI, L.P.

Fri, 14 Aug 2026 17:44:00 -0400

si-local-file:///var/storage/secattach/20260814/26933021.html

Form 4 Septerna, Inc. For: Aug 12 Filed by: Third Rock Ventures GP VI, L.P.

Fri, 14 Aug 2026 17:44:00 -0400

si-local-file:///var/storage/secattach/20260814/26933021.html

Form SCHEDULE 13D/A Septerna, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Fri, 14 Aug 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260814/26932763.html

Form SCHEDULE 13D/A Septerna, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Fri, 14 Aug 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260814/26932763.html

Form 4 Septerna, Inc. For: Aug 12 Filed by: Shah Rajeev M.

Fri, 14 Aug 2026 17:12:00 -0400

si-local-file:///var/storage/secattach/20260814/26932675.html

Form 4 Septerna, Inc. For: Aug 12 Filed by: Shah Rajeev M.

Fri, 14 Aug 2026 17:12:00 -0400

si-local-file:///var/storage/secattach/20260814/26932675.html

Form SCHEDULE 13G/A Septerna, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC

Fri, 14 Aug 2026 07:32:00 -0400

si-local-file:///var/storage/secattach/20260814/26924591.html

Form SCHEDULE 13G/A Septerna, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC

Fri, 14 Aug 2026 07:32:00 -0400

si-local-file:///var/storage/secattach/20260814/26924591.html

Form 4 Septerna, Inc. For: Aug 11 Filed by: Bhatt Elizabeth

Thu, 13 Aug 2026 19:00:00 -0400

si-local-file:///var/storage/secattach/20260813/26923106.html

Form 4 Septerna, Inc. For: Aug 11 Filed by: Bhatt Elizabeth

Thu, 13 Aug 2026 19:00:00 -0400

si-local-file:///var/storage/secattach/20260813/26923106.html

Septerna Inc (SEPN) PT Raised to $59 at Truist Securities

Thu, 13 Aug 2026 07:11:01 -0400

Truist Securities analyst Srikripa Devarakonda raised the price target on Septerna Inc (NASDAQ: SEPN) to $59.00 (from $43.00) while maintaining a Buy rating.

Form 144 Septerna, Inc. Filed by: RA Capital Healthcare Fund LP

Wed, 12 Aug 2026 19:07:00 -0400

si-local-file:///var/storage/secattach/20260812/26914758.html

Form 144 Septerna, Inc. Filed by: RA Capital Healthcare Fund LP

Wed, 12 Aug 2026 19:07:00 -0400

si-local-file:///var/storage/secattach/20260812/26914758.html

Form 144 Septerna, Inc. Filed by: RA Capital Nexus Fund III, L.P.

Wed, 12 Aug 2026 18:55:00 -0400

si-local-file:///var/storage/secattach/20260812/26914719.html

Form 144 Septerna, Inc. Filed by: RA Capital Nexus Fund III, L.P.

Wed, 12 Aug 2026 18:55:00 -0400

si-local-file:///var/storage/secattach/20260812/26914719.html

Form 144 Septerna, Inc. Filed by: Third Rock Ventures V, L.P.

Wed, 12 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260812/26912908.html

Form 144 Septerna, Inc. Filed by: Third Rock Ventures V, L.P.

Wed, 12 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260812/26912908.html